title: Treatment of metastatic melanoma in the brain with temozolomide and thalidomide.
authors.affiliation: Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. hwuw@mskcc.org
authors.forename: W J
authors.initials: WJ
authors.lastname: Hwu
authors.forename: J
authors.initials: J
authors.lastname: Raizer
authors.forename: K S
authors.initials: KS
authors.lastname: Panageas
authors.forename: E
authors.initials: E
authors.lastname: Lis
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D003606:Dacarbazine / Q000008:administration & dosage* / Q000031:analogs & derivatives; D004359:Drug Therapy, Combination; D005260:Female; D005625:Frontal Lobe; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary*; D012074:Remission Induction; D000077204:Temozolomide; D013792:Thalidomide / Q000008:administration & dosage*
chemical_list: D020533:Angiogenesis Inhibitors; D018906:Antineoplastic Agents, Alkylating; D013792:Thalidomide; D003606:Dacarbazine; D000077204:Temozolomide